News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Press Releases
Ipsen S.A. publishes its 2024 Half-Year Report (half-year ended 30 June 2024)
July 25, 2024
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Ipsen S.A. publishes its 2024 Half-Year Report (half-year ended 30 June 2024)
Attachment
2024 Ipsen Half-Year Financial Report
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Drug pricing
Pharma’s Reluctance To Serve Europe To Dodge MFN Drug Pricing Is Chilling
April 2, 2026
·
3 min read
·
Annalee Armstrong
Drug pricing
Trump’s MFN Pricing Expected To Delay More European Drug Launches
April 1, 2026
·
3 min read
·
Nick Paul Taylor
Clinical research
Pharma R&D Spend Drops 3.6% as Pipeline Prioritizations Take Shape
March 25, 2026
·
2 min read
·
Annalee Armstrong
Earnings
J&J Reigns as Top Pharma by Revenue While Lilly Leapfrogs on Strong Obesity Sales
March 18, 2026
·
8 min read
·
Tristan Manalac
